Medacta Group Valuation
| MOVE Stock | 110.60 0.20 0.18% |
At this time, the firm appears to be overvalued. Medacta Group SA secures a last-minute Real Value of USD102.86 per share. The latest price of the firm is USD110.6. Our model forecasts the value of Medacta Group SA from analyzing the firm fundamentals such as Profit Margin of 0.12 %, current valuation of 1.98 B, and Return On Equity of 0.21 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Medacta Group's price fluctuation is very steady at this time. Calculation of the real value of Medacta Group SA is based on 3 months time horizon. Increasing Medacta Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medacta stock is determined by what a typical buyer is willing to pay for full or partial control of Medacta Group SA. Since Medacta Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medacta Stock. However, Medacta Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 110.6 | Real 102.86 | Hype 110.6 |
The intrinsic value of Medacta Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medacta Group's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medacta Group SA helps investors to forecast how Medacta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medacta Group more accurately as focusing exclusively on Medacta Group's fundamentals will not take into account other important factors: Medacta Group Total Value Analysis
Medacta Group SA is now anticipated to have takeover price of 1.98 B with market capitalization of 2.08 B, debt of 63.17 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medacta Group fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.98 B | 2.08 B | 63.17 M |
Medacta Group Investor Information
About 70.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 23rd of May 2022. Based on the analysis of Medacta Group's profitability, liquidity, and operating efficiency, Medacta Group SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Medacta Group Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medacta Group has an asset utilization ratio of 74.22 percent. This indicates that the Company is making USD0.74 for each dollar of assets. An increasing asset utilization means that Medacta Group SA is more efficient with each dollar of assets it utilizes for everyday operations.Medacta Group Ownership Allocation
Medacta Group SA maintains a total of 19.98 Million outstanding shares. Medacta Group SA secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.53 % of Medacta Group SA outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medacta Group Profitability Analysis
The company reported the revenue of 363.13 M. Net Income was 51.52 M with profit before overhead, payroll, taxes, and interest of 261.25 M.About Medacta Group Valuation
Our relative valuation model uses a comparative analysis of Medacta Group. We calculate exposure to Medacta Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medacta Group's related companies.8 Steps to conduct Medacta Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medacta Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medacta Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medacta Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medacta Group's revenue streams: Identify Medacta Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medacta Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medacta Group's growth potential: Evaluate Medacta Group's management, business model, and growth potential.
- Determine Medacta Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medacta Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.